Does this adult patient have early HIV infection? The rational clinical examination systematic review

JAMA

Volumn 312, Issue 3, 2014, Pages 278-285

  Wood, Evan ^a,b   Kerr, Thomas ^a,b   Rowell, Greg ^c   Montaner, Julio S G ^a,b   Phillips, Peter ^a,b   Korthuis, P Todd ^d,e   Simel, David L ^f,g  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c FRASER HEALTH AUTHORITY   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRALGIA; CERVICAL LYMPHADENOPATHY; CLINICAL EXAMINATION; CLINICAL FEATURE; CONDYLOMA ACUMINATUM; DIARRHEA; EARLY DIAGNOSIS; FATIGUE; FEVER; FLU LIKE SYNDROME; GENITAL ULCER; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MACULOPAPULAR RASH; MOUTH ULCER; MYALGIA; NIGHT SWEAT; PHARYNGITIS; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RASH; RETROVIRUS INFECTION; REVIEW; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW; THRUSH; VOMITING; WEIGHT REDUCTION;

ADULT; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; LYMPHATIC DISEASES; PHYSICAL EXAMINATION; ULCER; VOMITING; WEIGHT LOSS;

EID: 84904252984     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.5954     Document Type: Review

References (72)

1. Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. http://www.unaids.org/en/media/unaids/ contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en. pdf. Accessed May 2013.
2. Centers for Disease Control and Prevention. HIV in the United States: at a glance; November 2013. http://www.cdc.gov/hiv/pdf/statistics-basics-factsheet. pdf. Accessed May 2013.
3. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 US dependent areas-2010. HIV Surveillance Supplemental Report 2012;17(3 part A). http://www.cdc.gov/hiv/pdf/statistics-2010-HIV-Surveillance-Report-vol- 17-no-3.pdf. Published June 2012. Accessed June 24, 2014.
4. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007-2010. HIV Surveillance Supplemental Report 2012;17(No. 4):December 2012. http://www.cdc.gov/hiv/surveillance/resources/reports/ 2010supp-vol17no4/. Accessed June 24, 2014.
5. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447-1450. (Pubitemid 43948252)
6. Dombrowski JC, Harrington RD, Golden MR. Evidence for the long-term stability of HIV transmission-associated sexual behavior after HIV diagnosis. Sex Transm Dis. 2013;40(1):41-45.
7. Kitahadta MM, Gange SJ, Abraham AG, et al NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815-1826.
8. El-Sadr WM, Lundgren J, Neaton JD, et al Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283-2296. (Pubitemid 44837777)
9. Cohen MS, Chen YQ, McCauley M, et al HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
10. Jia Z, Mao Y, Zang F, et al. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet. 2013;382(9899):1195-1203.
11. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
12. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet. 2011;378(9787):256- 268.
13. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387-402.
14. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48-57.
15. Yerly S, Hirschel B. Diagnosing acute HIV infection. Expert Rev Anti Infect Ther. 2012;10(1):31-41.
16. 2013 Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents: considerations for antiretroviral use in special patient populations acute and Recent (Early*) HIV Infection. http://www.aidsinfo. nih.gov/contentfiles/lvguidelines/glchunk/glchunk-20.pdf. Updated June, 23, 2014. Accessed August 2013.
17. Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Immunodeficiency and the risk of death in HIV infection. JAMA. 1992;268(19):2662-2666.
18. Richey LE, Halperin J. Acute human immunodeficiency virus infection. Am J Med Sci. 2013;345(2):136-142.
19. McKellar MS, Cope AB, Gay CL, et al Duke-Unc Acute HIV Infection Consortium. Acute HIV-1 infection in the Southeastern United States: a cohort study. AIDS Res Hum Retroviruses. 2013;29(1):121-128.
20. Branson BM, Handsfield HH, Lampe MA, et al Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17.
21. Moyer VA; US Preventive Services Task Force. Screening for HIV: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(1):51-60.
22. Daar ES, Pilcher CD, Hecht FM. Clinical presentation and diagnosis of primary HIV-1 infection. Curr Opin HIV AIDS. 2008;3(1):10-15. (Pubitemid 351339923)
23. Herrin J, Wesolowski LG, Heffelfinger JD, et al. HIV screening practices and hospital characteristics in the US, 2009-2010. Public Health Rep. 2013;128(3):161-169.
24. Ellis S, Curtis H, Ong EL; British HIV Association (BHIVA); BHIVA Clinical Audit and Standards sub-committee. HIV diagnoses and missed opportunities: results of the British HIV Association (BHIVA) national audit 2010. Clin Med. 2012;12(5):430-434.
25. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33-39.
26. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med. 2011;364(20):1943-1954.
27. Vanhems P, Lambert J, Cooper DA, et al. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis. 1998;26(2):323-329. (Pubitemid 28083941)
28. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272(5265):1167-1170. (Pubitemid 26001148)
29. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR; Hedges Team. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ. 2005;330(7501):1179.
30. Simel DL, Rennie D, eds. Rational Clinical Examination: The Evidence-Based Clinical Diagnosis. New York, NY: McGraw-Hill; 2008:9-16.
31. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
32. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:9.
33. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2011: Surveillance Report, 2011. http://www.cdc.gov/hiv/library/reports/surveillance/2011/surveillance-report- vol-23.html. Published February 2013. Accessed June 24, 2014.
34. World Health Organization. Data on the size of the HIV/AIDS epidemic: Prevalence of HIV among adults aged 15 to 49 (%) by country. http://apps.who.int/gho/data/node.main.622?lang=en Accessed September 10, 2013.
35. Simel DL, Easter J, Tomlinson G. Likelihood ratios, sensitivity, and specificity values can be back-calculated when the odds ratios are known. J Clin Epidemiol. 2013;66(4):458-460.
36. Simel DL, Bossuyt PM. Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. J Clin Epidemiol. 2009;62(12):1292-1300.
37. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
38. Higgins JP, Thompson SG. Quantifying heterogeneity in ameta-analysis. Stat Med. 2002;21(11):1539-1558.
39. Borenstein MHL, Higgins J, Rothstein H. Introduction to Meta-Analysis. Wiley Online Library; 2009.
40. Zetola NM, Bernstein KT, Wong E, Louie B, Klausner JD. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immune Defic Syndr. 2009;50(5):546-551.
41. Sullivan PS, Fideli U, Wall KM, et al. Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009. AIDS. 2012;26(2):175-184.
42. Zetola NM, Kaplan B, Dowling T, et al. Prevalence and correlates of unknown HIV infection among patients seeking care in a public hospital emergency department. Public Health Rep. 2008;123(suppl 3):41-50.
43. Pincus JM, Crosby SS, Losina E, King ER, LaBelle C, Freedberg KA. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin Infect Dis. 2003;37(12):1699-1704. (Pubitemid 37549959)
44. Hsu DT, Ruf M, O'Shea S, Costelloe S, Peck J, Tong C. Diagnosing HIV infection in patients presenting with glandular fever-like illness in primary care: are wemissing primary HIV infection? HIV Med. 2013;14(1):60-63.
45. Coco A, Kleinhans E. Prevalence of primary HIV infection in symptomatic ambulatory patients. Ann Fam Med. 2005;3(5):400-404. (Pubitemid 41512656)
46. Fontaine A, Larue F, Lassaunière JM. Physicians' recognition of the symptoms experienced by HIV patients: how reliable? J Pain Symptom Manage. 1999;18(4):263-270. (Pubitemid 29469704)
47. Paauw DS, Wenrich MD, Curtis JR, Carline JD, Ramsey PG. Ability of primary care physicians to recognize physical findings associated with HIV infection. JAMA. 1995;274(17):1380-1382.
48. Coates RA, Fanning MM, Johnson JK, Calzavara L. Assessment of generalized lymphadenopathy in AIDS research: the degree of clinical agreement. J Clin Epidemiol. 1988;41(3):267-273. (Pubitemid 18069587)
49. Mlisana K, Sobieszczyk M, Werner L, et al. Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing. PLoS One. 2013;8(4):e62928.
50. Sharghi N, Bosch RJ, Mayer K, Essex M, Seage GR III. The development and utility of a clinical algorithm to predict early HIV-1 infection. J Acquir Immune Defic Syndr. 2005;40(4):472-478. (Pubitemid 41669183)
51. Wahome E, Fegan G, Okuku HS, et al. Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya. AIDS. 2013;27(13):2163-2166.
52. Powers KA, Miller WC, Pilcher CD, et al Malawi UNC Project Acute HIV Study Team. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS. 2007;21(16):2237-2242. (Pubitemid 350287223)
53. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA. 1997;278(23):2085-2089. (Pubitemid 28016231)
54. Hofer CB, Harrison LH, Struchiner CJ, et al Projecto Praça Onze Study Group. Acute retrovirus syndrome among prospectively identified homosexual men with incident HIV infection in Brazil. J Acquir Immune Defic Syndr. 2000;25(2):188-191.
55. Lemonovich TL, Watkins RR, Morrison CS, et al Differences in clinical manifestations of acute and early HIV-1 infection between HIV-1 subtypes in African women [published online October 8, 2014]. J Int Assoc Provid AIDS Care. 2013.
56. Sanchez J, Lama JR, Peinado J, et al. High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention. J Acquir Immune Defic Syndr. 2009;51(suppl 1):S47-S51.
57. Marmor M, Titus S, Harrison C, et al. Weight loss associated with HIV seroconversion among injection-drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12(5):514-518. (Pubitemid 26274943)
58. Lavreys L, Thompson ML, Martin HL Jr, et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis. 2000;30(3):486-490. (Pubitemid 30205293)
59. Fox R, Eldred LJ, Fuchs EJ, et al. Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men. AIDS. 1987;1(1):35-38. (Pubitemid 18048272)
60. Morgan D, Mahe C, Whitworth J. Absence of a recognizable seroconversion illness in Africans infected with HIV-1. AIDS. 2001;15(12):1575-1576. (Pubitemid 32746973)
61. Krämer A, Biggar RJ, Hampl H, et al. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Am J Epidemiol. 1992;136(1):71-80.
62. Mientjes GH, van Ameijden EJ, Weigel HM, van den Hoek JA, Coutinho RA. Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers. BMJ. 1993;306(6874):371-373. (Pubitemid 23039395)
63. Fox PA, Hawkins DA, Boag FC. HIV seroconversion illness following acute hepatitis A. Sex Transm Infect. 1999;75(2):133. (Pubitemid 29237012)
64. Boyko WJ, Schechter MT, Craib KJ, et al. The Vancouver Lymphadenopathy-AIDS Study: 7. Clinical and laboratory features of 87 cases of primary HIV infection. CMAJ. 1987;137(2):109-113. (Pubitemid 17103147)
65. Pilcher CD, Price MA, Hoffman IF, et al. Frequent detection of acute primary HIV infection in men in Malawi. AIDS. 2004;18(3):517-524. (Pubitemid 38365880)
66. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis. 1997;24(5):965-970. (Pubitemid 27193886)
67. Vanhems P, Routy JP, Hirschel B, et al Collaborative Group. Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age. J Acquir Immune Defic Syndr. 2002;31(3):318-321. (Pubitemid 35278632)
68. Pilcher CD, McPherson JT, Leone PA, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA. 2002;288(2):216-221. (Pubitemid 34755282)
69. Caponetti G, Pantanowitz L. HIV-associated lymphadenopathy. Ear Nose Throat J. 2008;87(7):374-375. (Pubitemid 352035979)
70. Motyckova G, Steensma DP. Why does my patient have lymphadenopathy or splenomegaly? Hematol Oncol Clin North Am. 2012;26(2):395-408.
71. Schmid GP. Approach to the patient with genital ulcer disease. Med Clin North Am. 1990;74(6):1559-1572. (Pubitemid 20384862)
72. UNAIDS. Report on the Global HIV/AIDS Epidemic. Geneva, Switzerland: UNAIDS and World Health Organization; November 2012: http://www.unaids.org/en/ media/unaids/contentassets/documents/epidemiology/2012/gr2012/ 20121120-unaids-global-report-2012-with-annexes-en.pdf. Accessed June 24, 2014.